Company profile
AstronauTx Developing therapeutics to treat neurological disorders by improving sleep architecture
Astronautx Limited is a UK company with status active founded in 2019 based in North West England.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
CS01 | Transaction MzUxNTM4OTQzMmFkaXF6a2N4
Published 10 Apr 2026 14:01
Last confirmation statement made up date
Last accounts made up date
AA01 | Transaction MzQ0MjAyNzU2NGFkaXF6a2N4
Published 05 Nov 2024 10:59
TM01 | Transaction MzQzODczMTg5MGFkaXF6a2N4
Published 08 Oct 2024 12:32
TM01 | Transaction MzQzODczMTg4OWFkaXF6a2N4
Published 08 Oct 2024 12:32
AA | Transaction MzQzNzE2OTI2M2FkaXF6a2N4 | Paper/PDF filed
Published 30 Sep 2024 05:39
AP01 | Transaction MzQzNzUzNDU5MWFkaXF6a2N4
Published 27 Sep 2024 02:01
Company registered at Companies House
AstronauTx develops pharmaceuticals for the treatment of neurodegenerative diseases such as Alzheimer's.
Astrocytes are an abundant cell type in the brain that support neuronal firing, metabolism and blood-brain barrier function in a healthy brain, however in disease they can exacerbate and even drive neurotoxicity. AstronauTx is a DDF-formed company targeting astrocytes to restore their homeostatic function as treatments for dementias. I am a scientific co-founder in receipt fo founder equity and member of their advisory board.
None as yet
None as yet.
1 Oct 2023 to 31 Mar 2025
AstronauTx is a biotechnology company focussed on developing new drugs for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. These diseases carry a huge burden to patients, caregivers and society as a whole. With an aging population, this societal cost will double in the next 10 years. Current therapies for these diseases are...
